+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905050
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Allergy immunotherapy is rapidly evolving as a strategic therapeutic solution, driven by advances in drug delivery systems and increasing demand for durable, disease-modifying treatments. Senior leadership across life sciences, healthcare provision, and investment sectors will find actionable insight within this analysis of the Allergy Immunotherapy Market.

Market Snapshot: Allergy Immunotherapy Market Growth and Outlook

The Allergy Immunotherapy Market grew from USD 1.86 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 10.03%, reaching USD 3.30 billion by 2030. This trajectory reflects increased adoption by clinicians, product launches incorporating innovative delivery platforms, and rising global allergy prevalence. Payers, patients, and manufacturers are aligning around long-term symptom management and the potential for health system savings associated with immunotherapies.

Scope & Segmentation

This market research delivers a structured, segmented analysis to illuminate drivers, barriers, and opportunities across the following categories:

  • Treatment Type: Epicutaneous, oral, subcutaneous, and sublingual immunotherapy options serve diverse clinical needs and patient profiles.
  • Allergen Type: Animal dander (including cat and dog allergens), dust mites, food allergens (such as egg, milk, peanut, and tree nut), and pollen.
  • Immunotherapy Delivery Form: Dermal patches, drops, injections, and tablets offer tailored patient and provider preferences.
  • Technology Platform: Adjuvants, nanotechnology-based systems, and recombinant allergen technologies drive efficacy and innovation.
  • Allergy Type: Allergic asthma, allergic rhinitis, atopic dermatitis, and urticaria anchor demand across disease states.
  • End User: Homecare, hospitals, research and academic laboratories, specialty clinics.
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacies.
  • Region: Americas (including U.S. states and Latin American countries), Europe, Middle East & Africa, and Asia-Pacific with distinct regulatory and reimbursement environments.
  • Key Companies: ALK-Abelló, Allergy Therapeutics, Anergis SA, Biomay AG, BioSpace, F. Hoffmann-La Roche, GlaxoSmithKline, HAL Allergy, Jubilant HollisterStier, and Merck KGaA.

Key Takeaways for Senior Decision-Makers

  • Innovative delivery systems, such as needle-free dermal patches and patient-friendly oral formats, are expanding access and improving adherence rates.
  • Technology advancements—including nanotechnology and recombinant allergens—are facilitating more precise immune targeting and streamlined clinical development.
  • Collaborative alliances and partnerships between biopharma, digital health, and specialty clinics are accelerating product launches and supporting real-world evidence generation.
  • Manufacturers are proactively restructuring global supply chains through diversification and risk mitigation, responding to dynamic regulatory and reimbursement environments.
  • Emerging indications, particularly for atopic dermatitis and urticaria, present open avenues for portfolio expansion and address unmet clinical needs.
  • Regional variations in reimbursement, regulatory requirements, and healthcare infrastructure require adaptable go-to-market strategies for sustained growth.

Tariff Impact and Supply Chain Strategy

Recent proposals for new U.S. tariffs on biopharmaceutical imports are shaping procurement strategies and supplier diversification across the allergy immunotherapy sector. Companies are negotiating long-term domestic supply contracts and adopting lean inventory models to offset potential disruptions. Industry groups advocate for tariff exemptions to protect patient access, while global manufacturers reinforce resilience through vertical integration and cross-jurisdiction supplier networks.

Methodology & Data Sources

This report utilizes a multi-stage, evidence-based research methodology combining secondary sources (peer-reviewed journals, regulatory filings, clinical trial data) and expert interviews with healthcare professionals, payers, and patient advocates. Quantitative data is validated through triangulation and analytic techniques, resulting in actionable, reliable insights for strategic planning.

Why This Report Matters

  • Enables leadership to benchmark current market positioning and inform investment, R&D, and commercial strategy in alignment with evolving regulatory demands.
  • Equips pharmaceutical, biotech, and healthcare executives to identify supply chain vulnerabilities, optimize pricing models, and target high-value indications for differentiation.

This report also supports decision-makers in navigating payer trends, integrating patient-centric innovation, and unlocking regional growth opportunities within the allergy immunotherapy landscape.

Conclusion

Allergy immunotherapy is positioned at the intersection of scientific innovation, regulatory transformation, and patient-centered care. Stakeholders who prioritize adaptable strategies and cross-sector collaboration will be best equipped to shape market trajectory and address evolving global health needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of sublingual immunotherapy tablets driven by patient preference and home-based treatment adoption
5.2. Adoption of digital adherence monitoring devices to improve compliance in allergy immunotherapy regimens
5.3. Emergence of personalized allergen immunotherapy guided by component-resolved diagnostics and biomarkers
5.4. Rising investments in peptide-based vaccines addressing multi-allergen sensitization in pediatric patients
5.5. Expansion of biologics targeting allergic asthma and chronic urticaria with improved efficacy profiles
5.6. Impact of telehealth integration on remote allergy evaluation and customized immunotherapy adjustments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Allergy Immunotherapy Market, by Treatment Type
8.1. Introduction
8.2. Epicutaneous Immunotherapy
8.3. Oral Immunotherapy
8.4. Subcutaneous Immunotherapy
8.5. Sublingual Immunotherapy
9. Allergy Immunotherapy Market, by Allergen Type
9.1. Introduction
9.2. Animal Dander
9.2.1. Cat Allergens
9.2.2. Dog Allergens
9.3. Dust Mites
9.4. Food Allergens
9.4.1. Egg Allergens
9.4.2. Milk Allergens
9.4.3. Peanut Allergens
9.4.4. Tree Nut Allergens
9.5. Pollen
10. Allergy Immunotherapy Market, by Immunotherapy Delivery Form
10.1. Introduction
10.2. Dermal Patch
10.3. Drops
10.4. Injections
10.5. Tablets
11. Allergy Immunotherapy Market, by Technology Platform
11.1. Introduction
11.2. Adjuvants
11.3. Nanotechnology-Based Platforms
11.4. Recombinant Allergens
12. Allergy Immunotherapy Market, by Allergy Type
12.1. Introduction
12.2. Allergic Asthma
12.3. Allergic Rhinitis
12.4. Atopic Dermatitis
12.5. Urticaria
13. Allergy Immunotherapy Market, by End User
13.1. Introduction
13.2. Homecare Settings
13.3. Hospitals
13.4. Research & Academic Laboratories
13.5. Specialty Clinics
14. Allergy Immunotherapy Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.4. Retail Pharmacy
15. Americas Allergy Immunotherapy Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Allergy Immunotherapy Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Allergy Immunotherapy Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ALK-Abelló, Inc.
18.3.2. Allergy Therapeutics PLC
18.3.3. Anergis SA
18.3.4. Biomay AG
18.3.5. BioSpace, Inc.
18.3.6. F. Hoffmann-La Roche Ltd.
18.3.7. GlaxoSmithKline plc
18.3.8. HAL Allergy B.V.
18.3.9. Jubilant HollisterStier LLC
18.3.10. Merck KGaA
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ALLERGY IMMUNOTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. ALLERGY IMMUNOTHERAPY MARKET: RESEARCHAI
FIGURE 30. ALLERGY IMMUNOTHERAPY MARKET: RESEARCHSTATISTICS
FIGURE 31. ALLERGY IMMUNOTHERAPY MARKET: RESEARCHCONTACTS
FIGURE 32. ALLERGY IMMUNOTHERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 136. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 137. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 138. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 139. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 140. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 141. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 142. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 143. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 264. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 265. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 266. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 267. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 268. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 269. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 270. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 271. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 298. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 299. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 300. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 301. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 302. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 303. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 304. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 305. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 306. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 307. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2024 (USD MILLION)
TABLE 318. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2025-2030 (USD MILLION)
TABLE 319. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2024 (USD MILLION)
TABLE 320. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2025-2030 (USD MILLION)
TABLE 321. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2024 (USD MILLION)
TABLE 322. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2025-2030 (USD MILLION)
TABLE 323. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 324. SPAIN ALLERGY IMMUNOTHERAPY MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

  • ALK-Abelló, Inc.
  • Allergy Therapeutics PLC
  • Anergis SA
  • Biomay AG
  • BioSpace, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • HAL Allergy B.V.
  • Jubilant HollisterStier LLC
  • Merck KGaA

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.3 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Allergy Vaccine Market by Route Of Administration (Subcutaneous Immunotherapy, Sublingual Immunotherapy), Allergens Targeted (Perennial Allergens, Seasonal Allergens), Vaccine Type, Distribution Channel, Technology, Patient Age Group, End User - Global Forecast 2025-2030 - Product Image

Allergy Vaccine Market by Route Of Administration (Subcutaneous Immunotherapy, Sublingual Immunotherapy), Allergens Targeted (Perennial Allergens, Seasonal Allergens), Vaccine Type, Distribution Channel, Technology, Patient Age Group, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Allergy Treatment Market by Treatment Type (Allergen Immunotherapy, Over The Counter Drugs, Prescription Drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Allergy Type, End User - Global Forecast 2025-2030 - Product Image

Allergy Treatment Market by Treatment Type (Allergen Immunotherapy, Over The Counter Drugs, Prescription Drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Allergy Type, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 184 Pages
  • Global
From
Allergy Shots - Global Strategic Business Report - Product Image

Allergy Shots - Global Strategic Business Report

  • Report
  • 584 Pages
  • Global
From
Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033 - Product Image

Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From

About the Allergy Immunotherapy Market

Allergy Immunotherapy is a form of treatment for allergies that involves administering small doses of allergens to the patient over a period of time. This helps the patient build up a tolerance to the allergens, reducing the severity of their allergic reactions. Allergy Immunotherapy is often used in conjunction with other forms of allergy treatment, such as antihistamines and decongestants. Allergy Immunotherapy is a growing market, with a variety of products available to treat different types of allergies. These products range from sublingual drops and tablets to injections and nasal sprays. Many of these products are available over the counter, while others require a prescription from a doctor. The Allergy Immunotherapy market is highly competitive, with many companies offering products to treat different types of allergies. Some of the major players in the market include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, and Circassia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.